Ricoh Company Ltd.
Ideas Unbound
Driving Progress in Drug Discovery and Regenerative Medicine through the Synergy of Biotechnology and Digital Technologies.
To solve issues such as screening of candidate substances and streamlining of API manufacturing in new drug development, the Ricoh Group provides a wide range of one-stop services from iPS cell differentiation to non-clinical pharmacological studies and analysis of candidate substances, as well as contract mRNA manufacturing, design and consulting services in Japan that lead to prompt and efficient supply of APIs.
3-25-22 Tonomachi LIC412, Kawasaki-ku, Kawasaki
Life Innovation Center (LIC)
Drug Discovery/Drug Discovery Support
